Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2012
11/01/2012CA2834527A1 Tolerogenic synthetic nanocarriers to reduce antibody responses
11/01/2012CA2834519A1 Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
11/01/2012CA2834514A1 Tolerogenic synthetic nanocarriers
11/01/2012CA2834365A1 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
11/01/2012CA2834353A1 Liposomal vancomycin for the treatment of mrsa infections
11/01/2012CA2834349A1 Liposomal formulations
11/01/2012CA2834262A1 Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
11/01/2012CA2834212A1 Layer processing for pharmaceuticals
11/01/2012CA2834063A1 Administration of iloprost as aerosol bolus
11/01/2012CA2834040A1 Intravascular delivery of nanoparticle compositions and uses thereof
11/01/2012CA2834028A1 Stable pharmaceutical composition
11/01/2012CA2833385A1 Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
11/01/2012CA2833115A1 Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
11/01/2012CA2832663A1 Risperidone sustained release microsphere composition
10/2012
10/31/2012EP2518040A1 Low-viscosity liquid-crystal compound
10/31/2012EP2518014A1 Carbon microparticle and process for production thereof
10/31/2012EP2517710A1 Tamper-resistant oral opioid agonist formulations
10/31/2012EP2517704A1 Pharmaceutical composition for treating parkinson's disease and preparation method thereof
10/31/2012EP2517697A1 Combination composition useful for treating cardiovascular diseases
10/31/2012EP2517696A1 Extended release memantine tablet
10/31/2012EP2517689A1 Hydrogel particles
10/31/2012EP2516508A2 Amphiphilic polymer functionalised by methionine
10/31/2012EP2516503A1 Antimicrobial polymers and methods of manufacture thereof
10/31/2012EP2516053A2 Emulsion-based process for preparing microparticles and workhead assembly for use with same
10/31/2012EP2516052A1 Epsilon-poly-lysine capsules
10/31/2012EP2516011A1 Carrier composition
10/31/2012EP2516010A2 Lipids, lipid compositions, and methods of using them
10/31/2012EP2515992A2 Swallowable drug delivery device and methods of drug delivery
10/31/2012EP2515956A1 COMPOSITION COMPRISING NANOPARTICLES OF TiO2
10/31/2012EP2515946A2 Nanoconjugates and nanoconjugate formulations
10/31/2012EP2515943A2 Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients
10/31/2012EP2515942A2 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
10/31/2012EP2515941A1 Antibody formulation
10/31/2012EP2515918A1 Smoking cessation lozenge containing tobacco alkaloid and silver salt
10/31/2012EP2515917A1 Compositions and methods for eye whitening
10/31/2012EP2515912A1 Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture
10/31/2012EP2515909A2 Fast dissolving pharmaceutical composition comprising lornoxicam
10/31/2012EP2515907A1 Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases
10/31/2012EP2515894A1 Compositions containing salmeterol, fluticasone and cromoglicic acid
10/31/2012EP2515888A1 Dry powder formulation containing tiotropium for inhalation
10/31/2012EP2515887A1 Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
10/31/2012EP2515886A2 Transdermal therapeutic system for administering rivastigmine or derivatives thereof
10/31/2012EP2515885A1 Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt
10/31/2012EP2515884A1 Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt
10/31/2012EP2515883A1 Abt-263 capsule
10/31/2012EP2515882A2 Controlled release pharmaceutical composition
10/31/2012EP2515881A2 Process for preparing tablets comprising 5- hydroxytryptophan and tryptophan
10/31/2012EP2515880A2 Novel pharmaceutical compositions of ranolazine
10/31/2012EP2515879A2 Fine particle croscarmellose and uses thereof
10/31/2012EP2515878A2 Sustained-release formulation
10/31/2012EP2515877A2 Degradable removable implant for the sustained release of an active compound
10/31/2012EP2515876A2 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
10/31/2012EP2515875A1 Polymerizable lactamic copolymers suitable for the formation of coatings on microencapsulated particles
10/31/2012EP2515874A2 Calcipotriol monohydrate nanocrystals
10/31/2012EP2515873A1 Formulation comprising 1 h - quinazoline - 2, 4 - dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof
10/31/2012EP2515872A1 Oral form of administration comprising entecavir
10/31/2012EP2515871A2 Solid pharmaceutical dosage form
10/31/2012EP2515870A2 Topical ophthalmic peptide formulation
10/31/2012EP2515869A2 Wound care products
10/31/2012EP2515868A1 Pharmaceutical compositions comprising igf-1 proteins, a buffering and a tonicity agent
10/31/2012EP2515867A2 Cell tissue gel containing collagen and hyaluronan
10/31/2012EP2515866A2 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
10/31/2012EP2515865A2 Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
10/31/2012EP2515864A1 Sustained release delivery devices
10/31/2012EP2515863A2 Slow release pharmaceutical compositions of iloperidone
10/31/2012EP2515862A1 Rapidly dispersing pharmaceutical formulation with cefdinir
10/31/2012EP2515861A2 Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
10/31/2012EP2515860A1 Improved pharmaceutical compositions comprising cefdinir
10/31/2012EP2515859A1 Rapidly dispersing effervescent formulation
10/31/2012EP2515858A1 Pharmaceutical composition with high purity
10/31/2012EP2515857A1 The production method for effervescent tablet with cefdinir
10/31/2012EP2515856A2 Aerosol formulation for copd
10/31/2012EP2515855A2 Combination therapy for COPD
10/31/2012EP2515854A2 Aerosol formulation for copd
10/31/2012EP2515853A2 Combination therapy for COPD
10/31/2012EP2515852A1 Orodispersible tablet contained compacted sildenafil base
10/31/2012EP2515851A1 Treatment for inflammatory bowel disease
10/31/2012EP2515850A1 Pharmaceutical compositions comprising cefdinir as an active agent
10/31/2012EP2515849A1 Effervescent tablet and granule formulation comprising cefixime
10/31/2012EP2515848A1 Dry powder combination of tiotropium, a corticosteroid and a cromoglicic acid derivative
10/31/2012EP2515847A1 Combination of tiotropium, mometasone and a cromoglicic acid derivative in dry powder form
10/31/2012EP2515846A1 Dry powder combination of tiotropium, budesonide and a cromoglicic acid derivative
10/31/2012EP2515845A1 Dry powder combination of tiotropium, formoterol and a cromoglicic acid derivative
10/31/2012EP2515680A2 Active ingredient delivery system
10/31/2012EP2515647A1 Pheromone compositions and methods of use
10/31/2012EP2515645A1 Antifungal therapy
10/31/2012CN202505806U Patch for treatment of lower limb phlebophlogosis
10/31/2012CN102762647A Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
10/31/2012CN102762528A Low-Viscosity Liquid-Crystal Compound
10/31/2012CN102762205A Coated solid preparation
10/31/2012CN102762202A Taxane pro-emulsion formulations and methods making and using the same
10/31/2012CN102762199A Oral complex composition comprising pseudoephedrine and levocetirizine
10/31/2012CN102762198A Multi-unit compositions
10/31/2012CN102762197A Manufacture of chewing gum product with radiofrequency
10/31/2012CN102762196A Lyophilization methods, compositions, and kits
10/31/2012CN102762195A Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof
10/31/2012CN102762108A Liquid-filled chitosan-anionic liposoluble surfactant capsule dispersions
10/31/2012CN102757564A Preparation method and application of tree-like polyester-polyglycidol block polymer
10/31/2012CN102757555A Dequalinium chloride-polyethylene glycol-distearoyl phosphatidyl ethanolamine conjugated compound and resveratrol liposome modified thereby
10/31/2012CN102757471A Novel active cytidine disodium triphosphate compound and pharmaceutical composition thereof
1 ... 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 ... 2991